Intranasal Insulin May Have Pro-Cognitive Benefits
FRIDAY, June 30, 2023 (HealthDay News) — Intranasal insulin (INI) seems to have a beneficial effect on global cognition among patients with Alzheimer disease (AD)/mild cognitive impairment (MCI), according to a review published online June 28 in PLOS…
Learn MoreADA: Once-Weekly Icodec Superior for Reduction in HbA1c
WEDNESDAY, June 28, 2023 (HealthDay News) — For patients with insulin-naive type 2 diabetes, once-weekly icodec is superior for reduction in hemoglobin A1c (HbA1c), according to a study published online June 24 in the Journal of the American Medical …
Learn MoreADA: Glycemic Control Up With Weekly Icodec Versus Daily Insulin Glargine
MONDAY, June 26, 2023 (HealthDay News) — For adults with type 2 diabetes, glycemic control is significantly better with once-weekly icodec than once-daily insulin glargine U100, according to a study published online June 24 in the New England Journal…
Learn More2012 to 2015 Saw Rise in U.S. Insulin Prices
FRIDAY, June 16, 2023 (HealthDay News) — U.S. insulin prices substantially increased from 2012 to 2015; however, the introduction of new products has led to substantial discounting practices and lower net prices, according to a study published online…
Learn MoreFDA Clears New Insulin Pump and Algorithm-Based Software
THURSDAY, May 25, 2023 (HealthDay News) — The U.S. Food and Drug Administration (FDA) cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software (Beta Bionics) for use in people at least 6 years of age with type 1 diabetes.These two…
Learn MoreUn único tratamiento endoscópico podría reemplazar a la insulina para la diabetes tipo 2
LUNES, 1 de mayo de 2023 (HealthDay News) — ¿Podría un procedimiento que dura una hora y que implica aplicar una descarga a una parte de los intestinos significar el fin de la insulina para millones de personas con diabetes tipo 2?Tal vez, según un p…
Learn MoreDDW: Endoscopic Procedure May Eliminate Insulin Use in T2DM
TUESDAY, May 2, 2023 (HealthDay News) — Recellularization via electroporation therapy (ReCET) combined with glucagon-like peptide-1 receptor agonist (GLP1-RA) treatment is safe and feasible for type 2 diabetes and can eliminate the use of insulin the…
Learn MoreOne-Time Endoscopic Treatment Might Replace Insulin for People With Type 2 Diabetes
MONDAY, May 1, 2023 (HealthDay News) — Could a one-hour procedure that involves zapping a part of the intestines mean no more insulin for millions of folks with type 2 diabetes?Maybe, according to a small study scheduled for presentation next week at…
Learn MoreSanofi sigue a Lilly y Novo Nordisk, y reduce los precios de la insulina
VIERNES, 17 de marzo de 2023 (HealthDay News) — Sanofi Inc. se convirtió el jueves en la tercera compañía que anuncia que reducirá los precios de sus productos de insulina.La compañía francesa anunció que reducirá los precios en un 78 por ciento, y q…
Learn MoreSanofi Follows Lilly, Novo Nordisk in Cutting Insulin Prices
FRIDAY, March 17, 2023 (HealthDay News) — On Thursday, Sanofi became the third company to announce it will slash prices on its insulin products.The French company announced that it will cut prices by 78 percent and cap out-of-pocket charges for its i…
Learn More